key: cord-0998303-1dxtovxz authors: Zhang, Ju; Ding, Nan; Song, Yangzi; Song, Rui; Pan, Yang; Wang, Linghang; Yan, Shuo; Wang, Qi; Ma, Shanfang; Wei, Lirong; Yu, Fengting; Lu, Lianhe; Zhang, Fujie; Chen, Chen; Zeng, Hui title: Phylogenomic tracing of asymptomatic transmission in a COVID-19 outbreak date: 2021-03-22 journal: Innovation (N Y) DOI: 10.1016/j.xinn.2021.100099 sha: 79973f38653551cd7a0c670c3df2bb1b8e8441e7 doc_id: 998303 cord_uid: 1dxtovxz SARS-CoV-2 has caused over 100 million deaths and continues to spread rapidly around the world. Asymptomatic transmission of SARS-CoV-2 is the Achilles’ heel of COVID-19 public health control measure. Phylogenomic data on SARS-CoV-2 could provide more direct information about asymptomatic transmission. In the present study, using a novel MINERVA sequencing technology, we traced asymptomatic transmission of COVID-19 patients in Beijing, China. 178 close-contacts were quarantined, and 14 COVID-19 patients were laboratory-confirmed by RT-PCR. We provide direct phylogenomic evidence of asymptomatic transmission by constructing the median joining network in the cluster. This data could help us to determine whether the current symptom-based screening should cover asymptomatic persons. By January 31 st 2021, SARS-CoV-2 has infected over 100 million persons and lead to more than 2 million deaths worldwide 1 , posing unprecedented challenges for population heath, governments and public health agencies. The threat of severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) derives from not only its pathogenicity, but also high transmissibility [2] [3] [4] . SARS-CoV-2 could be spread in communities by direct contact, respiratory droplets and airborne transmission, and through indirect contact with contaminated objects, especially those under freezing conditions [5] [6] [7] [8] . Asymptomatic persons seem to play a major role in SARS-CoV-2 transmission 9-11 . Asymptomatic COVID-19 patients include pre-symptomatic individuals and those who will never develop symptoms (asymptomatic carriers) 12 East Respiratory Syndrome (MERS), pre-symptomatic COVID-19 patients have a high viral load 13, 14 and transmission capacity (accounts for estimated 48% and 62% of cases in Singapore and in China, respectively) 10, 15 . On the contrary, only limited epidemiological investigations have suggested transmission from asymptomatic carriers [16] [17] [18] [19] [20] . Associated surveys based on cross-sectional design could not discriminate pre-symptomatic patients and asymptomatic carriers. In addition, epidemiological investigations could not strictly rule out possibilities of infection by contaminated objects and aerosols in environment, especially in the endemic areas. Therefore, molecular evidence is urgently needed to elucidate the transmission chains containing asymptomatic carriers on the rapid epidemic. guidelines. All PCR results were collected from clinical data. The MINERVA sequencing strategy is used to obtain the viral genome sequences of SARS-CoV-2 from all available specimens related to the outbreak (details in the 1 st and 2 nd section of the supplemental text) 22 . Briefly, after human rRNA removal and DNA digestion, the meta-transcriptome libraries further underwent the whole viral genome enrichment using the TargetSeq One Cov Kit (iGeneTech, Beijing, China). The final viral-enriched libraries were sequenced on an Illumina NextSeq500 in 2x75bp pair-end mode. The approach generated 2.1 million (QRI: 2.95-12.59 million) viral reads per sample, respectively (Table S1 ). The sequencing data were deposited in the National Genomics Data Center, China National Center for Bioinformation (Accession number: PRJCA002533, Table S2 ). SNP Identification. I) Sequencing raw reads were trimmed to remove sequencing adaptors and low-quality bases (base quality < 20) with Cutadapt v1.15 24 . II) Clean reads were aligned to the reference genome of the SARS-CoV-2 (GenBank accession number NC_045512.2) using the Bowtie2 v2.2.5 25 with default parameters. III) Duplicate reads were removed with Picard Tools (v 1.141). IV) Samtools (v 1.10) 'mpileup' was used to call SNPs using mpileup files as input with parameter -Q 20. V) Each site was re-calculated and variants were screened using perl script with the following parameters: (1) depth of alternate allele ≥ 5, (2) alternate allele frequency ≥ 70%, and (3) discarding the sites only supported by a single strand. The C337T variant in P4 were also considered as an SNP that was supported by sequencing reads (with 67% frequency) and validated by Sanger sequencing. VI) Consensus sequences were called using BCFtools based on reference sequence. genomes (P1-P13) from the outbreak cluster and 72 local genomes mentioned above ( Figure S1 ). II) Median joining network was constructed using NETWORK v10.1.0.0 on the Fluxus Technology website (https://www.fluxus-engineering.com/). Step-by-step procedure including all the bioinformation commands and homemade scripts are organized and uploaded in biocode J o u r n a l P r e -p r o o f (https://bigd.big.ac.cn/biocode/tools/BT007092/releases/1.0) Contact period is defined from the date when P1 returned to Beijing (Feb 6) to the date when the close contacts were isolated (Feb 24). Isolation and hospitalization period is defined from the date of isolation to the date discharged from hospital of each patient, during which they were confined in the single room individually. The viral shedding duration is assessed from symptom onset to SARS-CoV-2 test turning negative. As for the asymptomatic cases, the day before the laboratory-confirmed is defined as their onset time. The clinical index patient (P1) of the outbreak, a 58-year-old female, came back from Hebei Province on Feb 6, 2020 and was released from home quarantine on Feb 13. She began to experience symptoms of a sore throat on Feb 18 and a fever three days later. On Table 1 & S5) , accounting for 35.7% in the outbreak cluster. Of note, no fever patient except for P1 was observed before isolation. Detailed clinical information of the patients is listed in Table 1 and the Supplementary information (Table S5, S6) . Of note, the viral shedding durations for the asymptomatic carriers were 11-52 days (median: 33 days), and 14-37 days for the symptomatic cases (median: 23 days; Figure 2 , Table 1 ). We retrospectively investigated the contact history. Six cases (P2-P5, P10 & P14) had no travel history. Eight cases (P1, P6-P9, P11-P13) left Beijing before Jan 24 th , 2020 and returned Beijing from Jan 29 th to Feb 13 th ( Table 1) (Table S1) . Thirteen high quality (coverage ≥ 70%) viral genomes were performed phylogenomic analysis together with 72 strains circulating in Beijing during the same period, Figure S3 , Table S7 ). Since the viral genomes from all the five asymptomatic patients were assigned on Clade I, we focused on the complete-genome diversity of Clade I. Accordingly, the genome from P9 was identical to the consensus genome in Beijing at the same period ( Figure 4A & S1) , and was selected as the closely related outgroup ( Figure 3B & 4B) . We identified five reliable consensus variants on Clade I, including two non-synonymous variants (C3429T and C18512T) and three synonymous variants (C337T, C6268T and C17119T; Figure 4A & S3, Table S7 ). Within them, C18512T, C337T and C17119T were inter-patient fixed variants. Among them, C18512T was observed in seven patients (P4-P7, P10-P12), C337T in five patients (P4-P6, P10 and P12) and C17119T in two patients (P6 and P12, Figure 4 ). According to these inter-patient fixed variants, we constructed the median joining network with NETWORK ( Figure 4B ). Of note, among the five asymptomatic patients, P4 and P5 were identified to get the second fixed mutation (C337T), which induced the subsequent SARS-CoV-2 transmission involving two asymptomatic patients (P6 and P12) and a symptomatic patient (P10). The important variant loci related to asymptomatic transmission have been covered by sequencing data (Table S4 ). Summarily, the determinant mutations in the transmission chains at least suggested the asymptomatic transmission was the reasonable deduction compatible with the available data, which was further supported by the epidemiological data ( Figure 1, Table 1 ). In the outbreak cluster, we observed that the asymptomatic carriers and minimally symptomatic patients (without fever) account for 35.7% and 28.6% of the cases (Table 1) , respectively, which is consistent with the previous studies 16, 17, 32, 33 . It was worth noting that the four minimally symptomatic patients did not realize their SARS-CoV-2 infections and were missed by mandatory temperature checks. Therefore, when discussing prevention and control strategies for COVID-19, the minimally symptomatic carriers should be managed the same as the asymptomatic cases 17 . Of note, all the patients in the outbreak have developed pneumonia and produced the IgG against the SARS-CoV-2 (Table 1, Figure S2 ), suggesting the complete inflammatory immune response and transmission risk even in the asymptomatic carriers 34 . Here, we provided direct phylogenomic evidence for the asymptomatic transmission of SARS-CoV-2. The viral genomes in this outbreak were mainly tightly clustered into two clades, of which all genomes from the five asymptomatic cases were assigned to Clade I ( Figure 3 ). Only one mutation C18512T (p.6083P>L, Nsp14) was identified in Clade I as non-synonymous mutation of three fixed SNPs, which were lack of functional data. In addition, this variant was not reported during the same period. Nsp14 is important for proofreading and replication of SARS-CoV-2 35,36 , however, more data are needed to investigate whether the mutation might cause more asymptomatic cases. By tracing the virus mutation accumulation during the apartment outbreak, we found two inter-patient fixed mutations (C337T and C17119T) were acquired in asymptomatic carriers (P4/P5 and P6/P12) and transmitted to others subsequently ( Figure 4B ). The transmission between P4/P5 or between P6/P12 might be also possible. The gradual accumulation of the viral SNPs could be observed, largely due to the closed management of the apartment building and the return of these individuals to Beijing at different times (Table 1 ). Of note, P10 who developed COVID-19 symptoms both on Feb 25, was infected by P4 or P5 ( Figure 4B ). This suggests that SARS-CoV-2 was transmitted from asymptomatic carriers to symptomatic patients, which was rarely evaluated in the current transmission model of COVID-19 2, 11 . It has been shown that the estimated R0 would dramatically increase when asymptomatic transmission is taken into the consideration 37, 38 . In addition, it was also worth noting the long viral shedding duration of the asymptomatic cases (P4, P11, Figure 2 ). If future studies could confirm the transmission ability of asymptomatic carriers at the later stages of infection, the risk of asymptomatic transmission would further increase. In the circumstance of lacking an efficient vaccine and specific antivirus medication, identifying and isolating patients is still considered as the most important strategy for containing SARS-CoV-2 transmission 31, 39 . The silent transmission chain of this novel virus mediated by large amount of asymptotic SARS-CoV-2 carriers underlines the important roles of these individuals in the viral transmission, and queries the current strategy of symptom-based screening 9, 11, 12, 17 . Given the increased PCR testing capacity and development of novel detection methods in many countries, expanding the screening system to asymptomatic carriers becomes both necessary and feasible [40] [41] [42] and results interpretation. The authors declare no competing interests. We collected clinical and tracing data of patients from information managing system of the Beijing Ditan hospital, as well as from publicly available data sources (published reports from Beijing public health agencies). All the information that we used is documented in the main text and supplementary data. Supplemental Information includes three figures, seven tables, supplemental methods, and supplemental results. yjs.ccmu.edu.cn/dweb/(S(sozol2imat5uibmrgwcm2ka3))/ds_jianjie.aspx?dm=20090010 The novel MINERVA sequencing technology reveals the accumulation of viral mutations during the asymptomatic transmission of SARS-CoV-2. Close-contacts of asymptomatic COVID-19 cases could develop into symptomatic patients. Phylogenomic tracing could efficiently support the epidemic investigations for COVID-19 outbreak. Coronavirus disease (COVID-19) pandemic. Geneva: World Health Organization Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia On the founder effect in COVID-19 outbreaks: how many infected travelers may have started them all? National Science Review Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution. mSystems Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID An index to quantify environmental risk of exposure to future epidemics of the COVID-19 and similar viral agents: Theory and practice Distribution of airborne SARS-CoV-2 and possible aerosol transmission in Wuhan hospitals Asymptomatic transmission, the Achilles' Heel of current strategies to control COVID-19 Temporal dynamics in viral shedding and transmissibility of COVID-19 High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2 Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing First Case of 2019 Novel Coronavirus in the United States SARS-CoV-2 viral load in upper respiratory specimens of infected patients Estimating the generation interval for coronavirus J o u r n a l P r e -p r o o f disease (COVID-19) based on symptom onset data Spread of SARS-CoV-2 in the Icelandic population Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility Superspreading event of SARS-CoV-2 infection at a bar Large SARS-CoV-2 outbreak caused by asymptomatic traveler Transmission potential of asymptomatic and paucisymptomatic severe acute respiratory syndrome coronavirus 2 infections: a 3-family cluster study in China Sources of technological innovation: Radical and incremental innovation problem-driven to support competitive advantage of firms MINERVA: A facile strategy for SARS-CoV-2 whole-genome deep sequencing of clinical samples Clinical management of COVID-19: interim guidance Cutadapt removes adapter sequences from high-throughput sequencing reads Fast gapped-read alignment with Bowtie 2 GSA: Genome Sequence Archive MAFFT multiple sequence alignment software version 7: improvements in performance and usability IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies TreeTime: Maximum-likelihood phylodynamic the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2 A novel COVID-19 epidemiological model with explicit susceptible and asymptomatic isolation compartments reveals unexpected consequences of timing social distancing A model describing COVID-19 community transmission taking into account asymptomatic carriers and risk mitigation Comparing containment measures among nations by epidemiological effects of COVID-19 Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From D-dimer level elevation can aid in detection of asymptomatic COVID-19 presenting with acute cerebral infarction Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art We thank all health care workers involved in the diagnosis and treatment of the COVID-19